<DOC>
	<DOCNO>NCT01485822</DOCNO>
	<brief_summary>The purpose study assess pigmentation trabecular meshwork patient treat least 2 year TRAVATAN compare patient without exposure ( less 1 month ) prostaglandin analogue ( PGA ) .</brief_summary>
	<brief_title>A Multicenter Study Pigmentation Trabecular Meshwork After Two Years Treatment With TRAVATAN 0.004 % Ophthalmic Solution</brief_title>
	<detailed_description />
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Travoprost</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Diagnosis openangle glaucoma without pseudoexfoliation pigment dispersion component ; Either two year dose Travatan , prior exposure ( less 1 month ) topical ocular prostaglandin ; Requires trabeculectomy ; Other protocoldefined inclusion criterion may apply . Pseudoexfoliation pigment dispersion ; History chronic recurrent severe inflammatory eye disease ; History current ocular infection ocular inflammation within past 3 month either eye ; Greater one month less two year exposure TRAVATAN ; Pregnant , breastfeeding , use highly effective birth control ; Other protocoldefined exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Glaucoma</keyword>
	<keyword>Travatan</keyword>
	<keyword>Trabeculectomy</keyword>
</DOC>